ValveCure
Corporate Financial Advisor and Board Level structuralist for Financial Analysis, Reporting, Accounting, Management Consulting, Healthcare Consulting and Corporate Law. Financial executive and business consultant as Principal of a successful investment banking firm and legal advisory group, managing companies from startup to $40,000,000 in annual revenues in the biotech/life science, ophthalmic, and renewable energy sectors.
Rob Kirk, JD, OD
Edward Hlozek, CEO and Chairman
Edward Hlozek, CEO and Chairman
CEO of Mind & Associates, Inc., Edward has been a senior level business executive, founder and Director of interventional and surgical/medical minimally invasive companies in cardiac, neurologic, orthopedic, urologic, gynecologic and ENT companies.
He has been responsible for financial and clinical introductory oversight for Class I, II & III devices for minimally invasive devices and techniques in all surgical specialties, including RF therapy devices. Designer and patent holder for the current transcatheter platform technologies of ValveCure.
Scientific Advisory Board
- David Adams, MD
- Peter Block, MD
- Randy Chitwood, MD
- Saibal Kar, MD
- Jeffrey Milliken, MD
